Thomas W. Grunt0000-0002-9899-5063
Thomas W. Grunt, born in 1958, received his M.S. and Ph.D. degrees from the University of Salzburg, Austria, in 1982 and 1985, respectively. From 1985 to 1987, he served as a Junior Scientist in research and development of two major pharmaceutical companies. In 1987, he joined the Laboratory for Applied and Experimental Tumor Cell Biology, Department of Chemotherapy, University of Vienna. In 1992/1993, he was a Research Fellow at the Vincent T. Lombardi Cancer Research Center, Georgetown University Medical Center, Georgetown University, Washington, and worked on the molecular crosstalk between the estrogen receptor and ErbB-2 in breast cancer. In 1993/1994, he became a Head of the Laboratory for Cell Growth and Differentiation, Division of Oncology, Department of Medicine I, University of Vienna. He was nominated Professor of Experimental Oncology and Cell Biology in 1997 from the University of Vienna and joined the University of British Columbia, Vancouver, BC, Canada, as a Visiting Professor in 2001. In the same year, he became the Director of Signaling Networks Program at the Medical University of Vienna. Since 2007, he serves also Administrative Director of the Ludwig Boltzmann Cluster Oncology, Vienna. He received several awards from the Austrian Association of Clinical Oncology and from the Austrian Society of Hematology and Oncology. He is Member of the Comprehensive Cancer Center at the Medical University of Vienna, he is also Member of AACR, EACR, ISD, and UICC. His major scientific interests are breast and ovarian cancer, growth factor signaling, cancer metabolism, cell differentiation, retinoids, endocrinology, neoplastic stem cells, and targeted drugs.
Biography Updated on 4 December 2011